Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 1;25(17):3711-5.
doi: 10.1016/j.bmcl.2015.06.031. Epub 2015 Jun 15.

Design, synthesis and evaluation of novel anti-HCV molecules that deliver intracellularly three highly potent NS5A inhibitors

Affiliations

Design, synthesis and evaluation of novel anti-HCV molecules that deliver intracellularly three highly potent NS5A inhibitors

Sebastien Boucle et al. Bioorg Med Chem Lett. .

Abstract

The design and synthesis of new non-symmetrical NS5A inhibitors with sulfur containing amino acids is reported along with their ability to block HCV replication in an HCV 1b replicon system. These compounds display EC50 values in the picomolar range with a large therapeutic index (>10(6)). Moreover, cellular pharmacology studies show that our preferred compounds intracellularly deliver three potent NS5A inhibitors.

Keywords: Antiviral; HCV; NS5A.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of BMS-790052, ABT-267 and GS-5885.
Figure 2
Figure 2
Delivery of three active molecules intracellularly.
Figure 3
Figure 3
Predicted binding of compounds 8c (a), 9 (b) and 10 (c) to Site-2 of NS5A associated with GT1b activity. NS5A dimer: chain A- gold ribbon and atoms; chain B- blue ribbon and atoms. Residues within 4.5Å of the inhibitor are displayed. a) Force field minimized analog 8c, with CH2SBn substitution, forms favorable packing interactions with R30, L31, and Y161 (blue arrow) of Site-2 consistent with low picomolar activity. b) CH2SOBn substitution of the minimized analog 9 (R) isomer is thought to reduced potency by destabilizing Bn packing with aromatic Y161 (orange arrow) c) Minimized analog 10, with CH2SO2Bn substitution, has restored predicted interactions with Y161 of WT receptor and similar potency to 8c.
Figure 4
Figure 4
Energy minimized binding of sulfone 10 in a two site model provides a structural rational for potent anti-HCV activity
Scheme 1
Scheme 1
Reagents and conditions: (a) ClCOOMe, NaOH 1 M, Na2CO3, 0 °C – rt, 18 h, 41-68%.
Scheme 2
Scheme 2
Reagents and conditions: (a) Br2, CH2Cl2, rt, overnight, 85%; (b) (i) Boc-L-Proline, DIPEA, rt, 5 h; (ii) NH4OAc, toluene, 130 °C, 4 h, 79%; (c) 6 N HCl, CH3OH, 50 °C, 5 h, 89%; (d) N-methoxycarbonyl-L-Valine, EDC, HOBt, DIPEA, CH3CN, 0 °C – rt, 3 h, 40%; (e) 2a-d, EDC, HOBt, DIPEA, CH3CN, 0 °C – rt, 3 h, 35-51%.
Scheme 3
Scheme 3
Reagents and conditions: (a) NaIO4, MeOH/H2O, rt, 3 h, 71%; (b) H2O2, Na2WO4.2H2O, BnN(Et)3Cl, 3 h, 49%;

References

    1. Kohler JJ, Nettles JH, Amblard F, Hurwitz SJ, Bassit L, Stanton RA, Ehteshami M, Schinazi RF. Infect. Drug Resist. 2014;7:41. - PMC - PubMed
    1. Pawlotsky J-M. J. Hepatol. 2013;59:375. - PubMed
    1. Halfon P, Locarnini SJ. Hepatol. 2011;55:192. - PubMed
    1. Coats SJ, Garnier-Amblard EC, Amblard F, Ehteshami M, Amiralaei S, Zhang H, Zhou L, Boucle SR, Lu X, Bondada L, Shelton JR, Li H, Liu P, Li C, Cho JH, Chavre SN, Zhou S, Mathew J, Schinazi RF. Antiviral res. 2014;102:119. - PMC - PubMed
    1. Zhang H, Zhou L, Amblard F, Shi J, Bobeck DR, Tao S, McBrayer TR, Tharnish PM, Whitaker T, Coats SJ, Schinazi RF. Bioorg. Med. Chem. Lett. 2012;22:4864. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources